Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Long Non-Coding Rnas As Potential Biomarkers or Therapeutic Targets in Gastric Cancer Publisher



Askari N1 ; Esfahani BS2 ; Parvizpour S3, 4 ; Shafieipour S5 ; Hadizadeh M6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Biotechnology, Institute of Sciences and High Technology and Environmental Sciences, Graduate University of Advanced Technology, End of Haft, Bagh-e-Alavi Highway, Kerman, Iran
  2. 2. Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran
  4. 4. Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran
  5. 5. Gastroenterology and Hepatology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran
  6. 6. Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran

Source: Gastroenterology and Hepatology from Bed to Bench Published:2023


Abstract

Aim: This study aimed to find lncRNAs and mRNAs that were expressed differently by combining microarray datasets from different studies. This was done to find important target genes in gastric cancer for anti-cancer therapy. Background: Gastric cancer (GC) is the fourth most frequent and second-most deadly malignancy worldwide. Thus, genetic diagnosis and treatment should focus on genetic and epigenetic variables. Based on several studies, disordered expression of noncoding RNAs (ncRNAs), such as lncRNAs, regulate gastric cancer invasion and metastasis. Besides, lncRNAs cooperatively regulate gene expression and GC progression. Methods: We obtained differentially expressed mRNAs (DEmRNAs) and lncRNAs (DElncRNAs) from three GC tissue microarray datasets by meta-analysis and screened genes using the Limma package. Then, using the RNAInter database, we allocated DEmRNAs to each DElncRNA. ClusterProfiler and GOplot programs were used to analyze function enrichment pathways and gene ontologies for final DEmRNAs. Results: A total of 9 differentially expressed lncRNAs (DElncRNAs) (5 up-regulated and 4 down-regulated), and 856 DEmRNAs (451 up-regulated and 405 down-regulated) between tumor and adjacent normal samples were found. Finally, 117 differentially expressed mRNAs were predicted as interactors of six DElncRNAs (H19, WT1-AS, EMX2OS, HOTAIR, ZEB1-AS1, and LINC00261). Conclusion: In order to promote cancer therapeutics and give knowledge on the process of carcinogenesis, our study projected a network of drug-gene interactions for discovered genes and presented relevant prospective biomarkers for the prognosis of patients with stomach cancer. © 2023 Research Institute for Gastroenterology and Liver Diseases. All rights reserved.
Experts (# of related papers)
Other Related Docs
19. Msi2 Expression Is Decreased in Grade Ii of Gastric Carcinoma, Pathology Research and Practice (2013)
26. Opposite Trends of Gas6 and Gas6-As Expressions in Breast Cancer Tissues, Experimental and Molecular Pathology (2021)
29. Exploring Conserved Mrna-Mirna Interactions in Colon and Lung Cancers, Gastroenterology and Hepatology from Bed to Bench (2017)
33. Emerging Roles for Lncrna-Neat1 in Colorectal Cancer, Cancer Cell International (2022)
36. Mir-146A Is Deregulated in Gastric Cancer, Journal of Cancer Research and Therapeutics (2019)
38. Long Non-Coding Rnas and Melanoma: From Diagnosis to Therapy, Pathology Research and Practice (2023)
40. Network Analysis of Common Genes Related to Esophageal, Gastric, and Colon Cancers, Gastroenterology and Hepatology from Bed to Bench (2017)
43. A Review on Expression and Regulatory Mechanisms of Mir-337-3P in Cancer, Journal of Biomolecular Structure and Dynamics (2024)